Equities

Tenon Medical Inc

TNON:NAQ

Tenon Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)5.47
  • Today's Change0.44 / 8.75%
  • Shares traded13.18m
  • 1 Year change-57.27%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.

  • Revenue in USD (TTM)3.37m
  • Net income in USD-13.87m
  • Incorporated2012
  • Employees21.00
  • Location
    Tenon Medical Inc104 Cooper Ct., Suite 6LOS GATOS 95032United StatesUSA
  • Phone+1 (408) 649-5760
  • Fax+1 (302) 655-5049
  • Websitehttps://www.tenonmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Arch Therapeutics Inc148.17k-12.99m2.27m8.00------15.30-3.69-3.690.0383-2.830.100.0662--18,521.25-828.03-188.28---804.6339.58---8,276.08-26,945.920.0051-1.32----383.83---32.35---21.76--
Nuwellis Inc9.01m-22.81m2.35m59.00------0.261-181.60-181.6048.48-13.250.82921.527.30152,779.70-192.57-98.07-301.19-122.4860.2855.22-232.24-230.510.7119-1.52----3.7612.14-55.78--4.61--
Optimus Healthcare Services Inc1.89m-7.16m2.46m12.00------1.30-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
Sonendo Inc37.46m-47.49m2.50m216.00--0.14--0.0668-0.5017-0.44360.39520.24530.4981.956.91173,421.30-63.14---78.26--35.04---126.79--1.73-8.540.5194--5.30---6.78------
Vycor Medical Inc1.36m-506.30k2.58m8.00------1.90-0.0155-0.01560.0417-0.10811.430.66945.08170,011.30-19.13-47.86----89.2389.60-13.38-35.420.0987-0.8001----19.43-0.654246.49---31.77--
SINTX Technologies Inc3.13m-8.60m2.59m43.00--0.2927--0.8271-271.52-271.5216.4411.820.18181.777.6372,697.67-50.01-45.71-62.67-57.3667.7258.47-275.14-681.801.79--0.0265--68.2994.2449.75--54.10--
Helius Medical Technologies Inc594.00k-8.84m2.61m22.00--0.4116--4.39-10.68-10.680.50421.980.06060.74864.4827,000.00-90.17-98.37-110.33-143.5712.7937.27-1,487.54-1,580.663.80--0.00---18.176.1437.11---41.95--
Invo Bioscience Inc5.77m-7.08m2.72m25.00------0.4706-3.24-3.242.440.35290.467712.0034.74230,781.20-57.44-94.63-116.03-151.4544.8974.91-122.80-343.110.2686-4.750.6588--267.3843.6226.24--87.09--
Heart Test Laboratories Inc18.60k-7.29m2.73m15.00--0.4568--146.82-5.65-5.650.00116.550.00350.0092--1,240.00-135.14---193.38--67.31---39,193.76--4.02-20.720.0777--261.17---3.95------
Acutus Medical Inc9.55m-9.70m2.97m233.00------0.3113-0.33010.09560.3261-0.13530.12111.141.4640,974.25-12.30-46.76-14.84-56.88-24.07-89.12-101.56-773.492.89-4.641.13--136.3627.03-141.35---35.99--
Tenon Medical Inc3.37m-13.87m3.09m21.00------0.9169-39.79-39.799.451.760.42522.275.27160,571.40-174.87---495.99--60.32---411.27--1.02--0.00--323.73--17.63------
ReShape Lifesciences Inc8.05m-9.02m3.29m31.00--1.08--0.4091-1.29-1.290.47660.10330.8820.80354.79259,548.40-98.88-136.06-169.55-194.3267.4756.30-112.11-408.360.8875--0.00---22.79-0.947475.36---49.29--
Fuse Medical Inc18.40m3.63m3.40m31.001.28--0.92160.18470.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Therapeutic Solutions International Inc91.38k-2.00m3.91m3.00--2.84--42.76-0.0005-0.00050.000020.00030.02521.295.2430,460.00-63.67-162.32-153.29--65.1867.79-2,530.31-2,391.850.3883-6.940.3164---52.1395.3543.11------
Kelyniam Global Inc517.70k-420.28k3.94m0.00--7.27--7.60-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Data as of Sep 20 2024. Currency figures normalised to Tenon Medical Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.